Subscribe to this topic via RSS or ATOM
Topic - Paul Knoepfler
No Stories Found
"This study provides reason for encouragement, but plans to now get such a treatment would be premature," said stem cell expert Paul Knoepfler of the University of California, Davis, who had no role in the research.
"I was getting more interested in embryonic stem cells and I knew California would be a more friendly climate for that," said Knoepfler, whose work focuses on why some embryonic stem cells trigger tumor growths.